Tag: cannabinoid

Blood Biomarker a ‘Promising Predictor’ of Psychosis Relapse

Copeptin, a small peptide secreted with the hormone vasopressin, appears to be one of the first promising biomarkers for predicting psychosis relapse, results of an...

CBD’s Role in Acute Pain Relief Tied to Patient Expectations

The pain-relieving effects of cannabidiol (CBD) may be linked to its influence on affective processes, new research shows. In a pilot study, investigators from the...

Marijuana Activists Offer #JointsforJabs to Back COVID Vaccination

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Marijuana legalization activists based in Washington, DC, set up tables at...

New Mexico Governor Signs Bill to Legalize Recreational Pot

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. SANTA FE, N.M. (AP) — New Mexico Gov. Michelle Lujan Grisham...

Opioid Use Common for Pain in Multiple Sclerosis

With chronic pain common among people with multiple sclerosis (MS), approximately 20% of patients report opioid use ― despite warnings that the drugs are generally...

Cannabinoids ‘Worth a Try’ for Agitation in Alzheimer’s

Tetrahydrocannabinol (THC), the psychoactive agent in cannabinoids, may provide an alternative to off-label use of antipsychotics and other medications to manage agitation in patients with...

FDA, Researchers Still in the Weeds on Cannabis, CBD, and Gender

The results of the election still remain murky, but with an additional five states legalizing medicinal or recreational cannabis use last month voters have sent a...

CBD Users May Test Positive for Marijuana on Urine Drug Screen

A new study discounts the assumption that people who use hemp-derived products will test negative for delta-9-tetrahydrocannabinol (THC), the psychoactive ingredient in marijuana. The small...

FDA Approves Clinical Trials for Cannabinoid Drug to Treat ARDS

The US Food and Drug Administration has approved phase one clinical trials for a synthetic cannabinoid drug designed to treat acute respiratory distress syndrome (ARDS),...

Frequent Cannabis Use in Depression Tripled Over Past Decade

Not only are individuals with depression at significantly higher risk for cannabis use compared with those without depression, this trend has increased dramatically over the...

CBD as Treatment for Cannabis Use Disorder?

Perhaps counterintuitively, treatment with prescription-grade cannabidiol (CBD), an extract of cannabis, may help individuals with cannabis use disorder to cut back on use, new research...

New Insight into Neurobehavioral Effects of Legalized Cannabis

Researchers have published one of the first studies to characterize the association between the consumption of legal cannabis and subsequent pharmacologic and neurobehavioral outcomes, with...